Swedish health-tech company, Brighter, has sold all shares in Camanio to Nasdaq Stockholm-listed AddLife, an independent European player in Life Science offering products, services and consulting to both the private and public sectors, for Skr65m (US$7.2m) in cash, including debt to be repaid by Camanio. The deal includes the sale of Camanio’s non-core assets Bestic,…
Home Healthcare Markets International News Sweden: Brighter sells Camanio to AddLife for Skr65m as part of streamlining